WebHere, we use RNAi technology to identify a novel oncogenic pathway that involves aberrant activation of the TYK2 tyrosine kinase and its downstream substrate, STAT1, which ultimately promotes T-ALL cell survival through the upregulation of BCL2 expression. ASJC Scopus subject areas Oncology Fingerprint WebNov 16, 2012 · Importantly, we found that expression of the anti-apoptotic gene BCL2 was significantly downregulated after silencing of both TYK2 and STAT1. Analysis by …
National Center for Biotechnology Information
WebMar 26, 2015 · The enhancement in STAT-1 activity and a down-regulation in Bcl-2 expression was also observed in MIN6 cells, another murine beta-cell derived line, after … WebAs BCL-2 and MCL-1 can be upregulated by STAT1 in anaplastic large cell lymphoma [9] and T-ALL [17], we hypothesized that these proteins may be subject to upregulation by STAT1 … delta precheck not on boarding pass
STAT1 Gene - GeneCards STAT1 Protein STAT1 Antibody
WebSep 19, 2024 · STAT1 −/− mice showed elevated colonic epithelial cell proliferation in early stages of injury-induced tumor formation and decreased apoptosis in advanced tumors with over-expression of the anti-apoptotic protein Bcl2 at the colon. STAT1 −/− mice showed increased accumulation of Ly6G + Ly6C − CD11b + cells in the spleen at 20 days of ... WebMar 26, 2015 · Tumor necrosis factor (TNF)-α and interferon (IFN)-γ are the major pro-inflammatory cytokines involved in beta-cell destruction. The fate of islet beta-cells in the cytokine-induced intrinsic mitochondrial apoptotic pathway is determined by the interaction between members of the Bcl-2 family. However, the mechanism through which beta-cell … WebNov 16, 2012 · Taken together, our findings indicate that aberrant activation of a TYK2-STAT1 pathway upregulates BCL2 expression in T-ALL cells, and that the T-ALL cells … fever charts